Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.

Perrin E RomineQin SunCatherine R Fedorenko Lily LiMariel TangKeith D Eaton Bernardo H L Goulart Renato G Martins

Published in: JCO oncology practice (2022)

Time to confirmation of NSCLC was inversely associated with OS in this US SEER population study. This association was lost when patients deceased within 6 months of diagnosis were excluded, suggesting that retrospective registry-claims databases may not be the optimal data source to study time to diagnosis as a quality metric because of the unaccounted confounding effects of tumor behavior. Prospective evaluations of clinically enriched data sources may better serve this purpose.

Keyphrases

small cell lung cancer
end stage renal disease
healthcare
chronic kidney disease
big data
electronic health record
prognostic factors
health insurance
quality improvement
adverse drug
tyrosine kinase